Vaccination

Major European nations suspend use of AstraZeneca vaccine

A cascading number of European countries—including Germany, France, Italy and Spain—suspended use of AstraZeneca's COVID-19 vaccine Monday over reports of dangerous blood clots in some recipients, though the company and ...

Vaccination

EXPLAINER: Why countries are halting the AstraZeneca shot

At least a dozen countries including Germany, France, Italy and Spain have now temporarily suspended their use of AstraZeneca's coronavirus vaccine after reports last week that some people in Denmark and Norway who got a ...

Diseases, Conditions, Syndromes

Dutch report ten possible AstraZeneca clot cases: watchdog

Ten cases of blot clots potentially linked to AstraZeneca's coronavirus vaccine have been reported in the Netherlands, the Dutch drugs watchdog said Monday after the government halted use of the jab.

Diseases, Conditions, Syndromes

Denmark, Norway, Iceland suspend use of AstraZeneca vaccine

Denmark, Norway and Iceland on Thursday temporarily suspended the use of AstraZeneca's COVID-19 vaccine over concerns about patients developing post-jab blood clots, as the manufacturer and Europe's medicines watchdog insisted ...

Diseases, Conditions, Syndromes

AstraZeneca vaccine effective in over-80s: study

The AstraZeneca/Oxford COVID-19 vaccine appears to be more than 80 percent effective at preventing severe illness among elderly, at-risk individuals after a single dose, according to preliminary research published Wednesday.

Vaccination

AstraZeneca expects updated COVID-19 vaccine by autumn

AstraZeneca said Thursday it expects to have a new version of its COVID-19 vaccine ready for use by this autumn as drugmakers respond to concerns about emerging variants of the disease that may be more transmissible or resistant ...

page 7 from 34